Development of a Smartphone-Based Expert System for COVID-19 Risk Prediction at Early Stage.

COVID-19 has imposed many challenges and barriers on traditional healthcare systems due to the high risk of being infected by the coronavirus. Modern electronic devices like smartphones with information technology can play an essential role in handling the current pandemic by contributing to different telemedical services. This study has focused on determining the presence of this virus by employing smartphone technology, as it is available to a large number of people. A publicly available COVID-19 dataset consisting of 33 features has been utilized to develop the aimed model, which can be collected from an in-house facility. The chosen dataset has 2.82% positive and 97.18% negative samples, demonstrating a high imbalance of class populations. The Adaptive Synthetic (ADASYN) has been applied to overcome the class imbalance problem with imbalanced data. Ten optimal features are chosen from the given 33 features, employing two different feature selection algorithms, such as K Best and recursive feature elimination methods. Mainly, three classification schemes, Random Forest (RF), eXtreme Gradient Boosting (XGB), and Support Vector Machine (SVM), have been applied for the ablation studies, where the accuracy from the XGB, RF, and SVM classifiers achieved 97.91%, 97.81%, and 73.37%, respectively. As the XGB algorithm confers the best results, it has been implemented in designing the Android operating system base and web applications. By analyzing 10 users' questionnaires, the developed expert system can predict the presence of COVID-19 in the human body of the primary suspect. The preprocessed data and codes are available on the GitHub repository.

An Improved Machine-Learning Approach for COVID-19 Prediction Using Harris Hawks Optimization and Feature Analysis Using SHAP.

A healthcare monitoring system needs the support of recent technologies such as artificial intelligence (AI), machine learning (ML), and big data, especially during the COVID-19 pandemic. This global pandemic has already taken millions of lives. Both infected and uninfected people have generated big data where AI and ML can use to combat and detect COVID-19 at an early stage. Motivated by this, an improved ML framework for the early detection of this disease is proposed in this paper. The state-of-the-art Harris hawks optimization (HHO) algorithm with an improved objective function is proposed and applied to optimize the hyperparameters of the ML algorithms, namely HHO-based eXtreme gradient boosting (HHOXGB), light gradient boosting (HHOLGB), categorical boosting (HHOCAT), random forest (HHORF) and support vector classifier (HHOSVC). An ensemble technique was applied to these optimized ML models to improve the prediction performance. Our proposed method was applied to publicly available big COVID-19 data and yielded a prediction accuracy of 92.38% using the ensemble model. In contrast, HHOXGB provided the highest accuracy of 92.23% as a single optimized model. The performance of the proposed method was compared with the traditional algorithms and other ML-based methods. In both cases, our proposed method performed better. Furthermore, not only the classification improvement, but also the features are analyzed in terms of feature importance calculated by SHapely adaptive exPlanations (SHAP) values. A graphical user interface is also discussed as a potential tool for nonspecialist users such as clinical staff and nurses. The processed data, trained model, and codes related to this study are available at GitHub.

COVID-19 pandemic: the existing challenges and available solution;evidence from a systematic review

Coronavirus disease (COVID-19) is presently the most important topic worldwide. However, no vaccine or specific anti-viral treatment for the disease has been shown to be effective. In this emergency identifying risk factors preventive measures and estimating challenges which control available drug options for COVID-19 are key to mitigating the severity of the pandemic until specific drugs or vaccines become available. Therefore, this study aims to identify possible factors which affect these drug options. This study searched PubMed database using necessary Boolean operators from December 31st to March 31st, 2020 in order to identify common risk factors preventive measures information regarding control challenges & evidence on the available drug options against COVID-19. Risk factors were found to be human-animal interactions males aged people and people with co-morbidity. Furthermore, protective factors comprised of personal hygiene etiquette maintenance rapid identification isolation and informing (3I tools) of the COVID-19 cases and media coverage on COVID-19. Till date anti-viral drugs like Remdesivir chloroquine lopinavir/ritonavir and traditional Chinese medicine (TCM) are available options to fight against COVID-19. More research is needed to determine other how to control the disease until specific treatment options are available as well as risk factors and preventive measures.

PreDTIs: prediction of drug-target interactions based on multiple feature information using gradient boosting framework with data balancing and feature selection techniques.

Discovering drug-target (protein) interactions (DTIs) is of great significance for researching and developing novel drugs, having a tremendous advantage to pharmaceutical industries and patients. However, the prediction of DTIs using wet-lab experimental methods is generally expensive and time-consuming. Therefore, different machine learning-based methods have been developed for this purpose, but there are still substantial unknown interactions needed to discover. Furthermore, data imbalance and feature dimensionality problems are a critical challenge in drug-target datasets, which can decrease the classifier performances that have not been significantly addressed yet. This paper proposed a novel drug-target interaction prediction method called PreDTIs. First, the feature vectors of the protein sequence are extracted by the pseudo-position-specific scoring matrix (PsePSSM), dipeptide composition (DC) and pseudo amino acid composition (PseAAC); and the drug is encoded with MACCS substructure fingerings. Besides, we propose a FastUS algorithm to handle the class imbalance problem and also develop a MoIFS algorithm to remove the irrelevant and redundant features for getting the best optimal features. Finally, balanced and optimal features are provided to the LightGBM Classifier to identify DTIs, and the 5-fold CV validation test method was applied to evaluate the prediction ability of the proposed method. Prediction results indicate that the proposed model PreDTIs is significantly superior to other existing methods in predicting DTIs, and our model could be used to discover new drugs for unknown disorders or infections, such as for the coronavirus disease 2019 using existing drugs compounds and severe acute respiratory syndrome coronavirus 2 protein sequences.

A Novel Bayesian Optimization-Based Machine Learning Framework for COVID-19 Detection From Inpatient Facility Data.

The whole world faces a pandemic situation due to the deadly virus, namely COVID-19. It takes considerable time to get the virus well-matured to be traced, and during this time, it may be transmitted among other people. To get rid of this unexpected situation, quick identification of COVID-19 patients is required. We have designed and optimized a machine learning-based framework using inpatient's facility data that will give a user-friendly, cost-effective, and time-efficient solution to this pandemic. The proposed framework uses Bayesian optimization to optimize the hyperparameters of the classifier and ADAptive SYNthetic (ADASYN) algorithm to balance the COVID and non-COVID classes of the dataset. Although the proposed technique has been applied to nine state-of-the-art classifiers to show the efficacy, it can be used to many classifiers and classification problems. It is evident from this study that eXtreme Gradient Boosting (XGB) provides the highest Kappa index of 97.00%. Compared to without ADASYN, our proposed approach yields an improvement in the kappa index of 96.94%. Besides, Bayesian optimization has been compared to grid search, random search to show efficiency. Furthermore, the most dominating features have been identified using SHapely Adaptive exPlanations (SHAP) analysis. A comparison has also been made among other related works. The proposed method is capable enough of tracing COVID patients spending less time than that of the conventional techniques. Finally, two potential applications, namely, clinically operable decision tree and decision support system, have been demonstrated to support clinical staff and build a recommender system.